{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T21:45:41Z","timestamp":1792014341789,"version":"4.4.0"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,10,10]],"date-time":"2019-10-10T00:00:00Z","timestamp":1570665600000},"content-version":"vor","delay-in-days":2261,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Royal Marsden National Institute for Health Research Biomedical Research Centre and Breakthrough Breast Cancer"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thebreastonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Breast"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1016\/j.breast.2013.07.007","type":"journal-article","created":{"date-parts":[[2013,9,27]],"date-time":"2013-09-27T13:50:40Z","timestamp":1380289840000},"page":"S38-S43","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":96,"special_numbering":"S2","title":["Sex hormones and breast cancer risk and prognosis"],"prefix":"10.1016","volume":"22","author":[{"given":"Elizabeth","family":"Folkerd","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitch","family":"Dowsett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.breast.2013.07.007_bib1","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S0140-6736(01)72384-7","article-title":"On the treatment of inoperable cases of carcinoma of the mamma: suggestions for a new method of treatment with illustrative cases","volume":"148","author":"Beatson","year":"1896","journal-title":"Lancet"},{"key":"10.1016\/j.breast.2013.07.007_bib2","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/S0140-6736(03)12342-2","article-title":"Overview of\u00a0the main outcomes in breast-cancer prevention trials","volume":"361","author":"Cuzick","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.breast.2013.07.007_bib3","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1093\/jnci\/dji372","article-title":"Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study","volume":"97","author":"Fisher","year":"2005","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.breast.2013.07.007_bib4","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1001\/jama.295.23.joc60074","article-title":"Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes","volume":"295","author":"Vogel","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.breast.2013.07.007_bib5","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0960-0760(93)90235-O","article-title":"Tissue-specific promotors regulate aromatase cytochrome P450 expression","volume":"44","author":"Simpson","year":"1993","journal-title":"J\u00a0Steroid Biochem Mol Biol"},{"key":"10.1016\/j.breast.2013.07.007_bib6","first-page":"649","article-title":"Reproducibility of plasma hormone levels in postmenopausal women over a 2\u20133 year period","volume":"4","author":"Hankinson","year":"1995","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.breast.2013.07.007_bib7","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1677\/joe.1.06264","article-title":"Is dehydroepiandrosterone a hormone?","volume":"187","author":"Labrie","year":"2005","journal-title":"J\u00a0Endocrinol"},{"key":"10.1016\/j.breast.2013.07.007_bib8","doi-asserted-by":"crossref","first-page":"4948","DOI":"10.1158\/1078-0432.CCR-11-0043","article-title":"Exploring breast cancer estrogen disposition: the basis for endocrine manipulation","volume":"17","author":"L\u00f8nning","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.breast.2013.07.007_bib9","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.steroids.2011.02.040","article-title":"Recent data on intratumor estrogens in breast cancer","volume":"76","author":"L\u00f8nning","year":"2011","journal-title":"Steroids"},{"key":"10.1016\/j.breast.2013.07.007_bib10","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jsbmb.2009.06.005","article-title":"Tissue estradiol is selectively elevated in receptor positive breast cancers while tumour estrone is reduced independent of receptor status","volume":"117","author":"L\u00f8nning","year":"2009","journal-title":"J\u00a0Steroid Biochem Mol Biol"},{"key":"10.1016\/j.breast.2013.07.007_bib11","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1158\/1078-0432.CCR-09-2481","article-title":"Intratumoral estrogen disposition in breast cancer","volume":"16","author":"Haynes","year":"2010","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.breast.2013.07.007_bib12","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1093\/jnci\/94.8.606","article-title":"Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies","volume":"94","author":"The Endogenous Hormones and Breast Cancer Collaborative Group","year":"2002","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.breast.2013.07.007_bib13","doi-asserted-by":"crossref","DOI":"10.1007\/s10549-012-2391-z","article-title":"Post menopausal plasma sex hormone levels and breast cancer risk over 20 years of follow-up","author":"Zhang","year":"2013","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.breast.2013.07.007_bib14","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1093\/jnci\/djj376","article-title":"Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women","volume":"98","author":"Eliassen","year":"2006","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.breast.2013.07.007_bib15","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/jnci\/dji132","article-title":"Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into cancer and nutrition (EPIC)","volume":"97","author":"Kaaks","year":"2005","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.breast.2013.07.007_bib16","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jsbmb.2006.07.011","article-title":"Influences on circulating oestrogens in postmenopausal women: relationship with breast cancer","volume":"103","author":"Kendall","year":"2007","journal-title":"J\u00a0Steroid Biochem Mol Biol"},{"key":"10.1016\/j.breast.2013.07.007_bib17","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/S0140-6736(01)06524-2","article-title":"Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease","volume":"358","author":"Collaborative group on hormonal factors in breast cancer","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.breast.2013.07.007_bib18","doi-asserted-by":"crossref","first-page":"4793","DOI":"10.1210\/jc.2009-0713","article-title":"Familial correlations in postmenopausal serum concentrations of sex steroid hormones and other mitogens: a twins and sisters study","volume":"94","author":"Stone","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.breast.2013.07.007_bib19","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/82533","article-title":"High constant incidence in twins and other relatives of women with breast cancer","volume":"26","author":"Peto","year":"2000","journal-title":"Nat Genet"},{"key":"10.1016\/j.breast.2013.07.007_bib20","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1056\/NEJM200007133430201","article-title":"Environmental and heritable factors in the causation of cancer-analyses of cohorts of twins from Sweden, Denmark, and Finland","volume":"343","author":"Lichtenstein","year":"2000","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.breast.2013.07.007_bib21","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1093\/jnci\/djh167","article-title":"Polymorphisms associated with circulating sex hormone levels in postmenopausal women","volume":"96","author":"Dunning","year":"2004","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.breast.2013.07.007_bib22","doi-asserted-by":"crossref","first-page":"e37815","DOI":"10.1371\/journal.pone.0037815","article-title":"Genome-wide association study of circulating estradiol, testosterone and sex hormone binding globulin in postmenopausal women","volume":"7","author":"Prescott","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.breast.2013.07.007_bib23","doi-asserted-by":"crossref","first-page":"e1002805","DOI":"10.1371\/journal.pgen.1002805","article-title":"A\u00a0genome-wide association meta-analysis of circulating sex hormone-binding globulin reveals multiple loci\u00a0implicated in sex steroid hormone regulation","volume":"8","author":"Coviello","year":"2012","journal-title":"PLoS Genet"},{"key":"10.1016\/j.breast.2013.07.007_bib24","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1093\/jnci\/djs156","article-title":"CYP3A variation, premenopausal estrone levels, and breast cancer risk","author":"Johnson","year":"2012","journal-title":"JNCI"},{"key":"10.1016\/j.breast.2013.07.007_bib25","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1093\/jnci\/djg022","article-title":"Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women","volume":"95","author":"Key","year":"2003","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.breast.2013.07.007_bib26","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/1097-0215(200002)9999:9999<::AID-IJC1053>3.0.CO;2-T","article-title":"Overweight as an avoidable cause of cancer in Europe","volume":"91","author":"Bergstr\u00f6m","year":"2001","journal-title":"Int J Cancer"},{"key":"10.1016\/j.breast.2013.07.007_bib27","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1200\/JCO.2010.29.7614","article-title":"Effect of obesity on prognosis after early-stage breast cancer","volume":"29","author":"Ewertz","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.breast.2013.07.007_bib28","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s10549-010-0990-0","article-title":"Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis","volume":"123","author":"Protani","year":"2010","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.breast.2013.07.007_bib29","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s10549-011-1914-3","article-title":"Pre-diagnosis body mass index and survival after breast cancer in the after breast cancer pooling project","volume":"132","author":"Kwan","year":"2012","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.breast.2013.07.007_bib30","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1200\/JCO.2010.33.2585","article-title":"Impact of body mass index on the efficacy of endocrine therapy in premenopausal patients with breast cancer: an analysis of the prospective ABCSG-12 trial","volume":"18","author":"Pfeiler","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.breast.2013.07.007_bib31","doi-asserted-by":"crossref","first-page":"3411","DOI":"10.1200\/JCO.2009.27.2021","article-title":"Effect of body mass index on recurrences in tamoxifen and anastrozole treated women: an exploratory analysis from the ATAC trial","volume":"21","author":"Sestak","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.breast.2013.07.007_bib32","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1677\/joe.0.0990455","article-title":"Antioestrogenic and antitumour activities of a series of non-steroidal antioestrogens","volume":"99","author":"Wakeling","year":"1983","journal-title":"J\u00a0Endocrinol"},{"key":"10.1016\/j.breast.2013.07.007_bib33","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1200\/JCO.2002.20.3.751","article-title":"Influence of letrozole and anastrozole on total body aromatization and plasma estrogen levels in postmenopausal breast cancer patients evaluated in a randomized cross-over study","volume":"20","author":"Geisler","year":"2002","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.breast.2013.07.007_bib34","first-page":"2089","article-title":"In\u00a0vivo inhibition of aromatization by exemestane, a novel irreversible aromatase inhibitor, in postmenopausal breast cancer patients","volume":"4","author":"Geisler","year":"1998","journal-title":"Clin Chem Res"},{"key":"10.1016\/j.breast.2013.07.007_bib35","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1200\/JCO.2012.42.0273","article-title":"Suppression of plasma estrogen levels by letrozole and anastrozole is related to body mass index in patients with breast cancer","volume":"30","author":"Folkerd","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.breast.2013.07.007_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2012.12.020","article-title":"Global changes in the mammary epigenome are induced by hormonal cues and coordinated by Ezh2","author":"Pal","year":"2013","journal-title":"Cell Rep"},{"key":"10.1016\/j.breast.2013.07.007_bib37","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1200\/JCO.2009.23.9616","article-title":"Relationship between plasma estradiol levels and estrogen-responsive gene expression in estrogen receptor-positive breast cancer in postmenopausal women","volume":"28","author":"Dunbier","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.breast.2013.07.007_bib38","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1186\/1471-2407-11-332","article-title":"Serum estradiol levels associated with\u00a0specific gene expression patterns in normal breast tissue and in breast carcinomas","volume":"11","author":"Haakensen","year":"2011","journal-title":"BMC Cancer"},{"key":"10.1016\/j.breast.2013.07.007_bib39","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jsbmb.2005.04.028","article-title":"Effects of anastrozole on the intratumoral gene expression in locally advanced breast cancer","volume":"95","author":"Kristensen","year":"2005","journal-title":"J\u00a0Steroid Biochem Mol Biol"},{"key":"10.1016\/j.breast.2013.07.007_bib40","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s10549-013-2426-0","article-title":"Expression of key estrogen-regulated genes differs substantially across the menstrual cycle in estrogen receptor-positive primary breast cancer","volume":"138","author":"Haynes","year":"2013","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.breast.2013.07.007_bib41","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/BF01806162","article-title":"Influence of plasma estrogen levels on the length of the disease-free interval in postmenopausal women with breast cancer","volume":"39","author":"L\u00f8nning","year":"1996","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.breast.2013.07.007_bib42","first-page":"3331","article-title":"Changes in estrogen receptor, progesterone receptor, and pS2 expression in tamoxifen-resistant human breast cancer","volume":"55","author":"Johnson","year":"1995","journal-title":"Cancer Res"},{"key":"10.1016\/j.breast.2013.07.007_bib43","doi-asserted-by":"crossref","first-page":"30458","DOI":"10.1074\/jbc.M305226200","article-title":"Enhanced estrogen receptor (ER) alpha, ERBB2, and MAPK signal transduction pathway operate during the adaptation of MCF-7 cells to long term estrogen deprivation","volume":"278","author":"Martin","year":"2003","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.breast.2013.07.007_bib44","doi-asserted-by":"crossref","unstructured":"McCormack VA, dos Santos Silva I. Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev; 15: 1159\u201369.","DOI":"10.1158\/1055-9965.EPI-06-0034"},{"key":"10.1016\/j.breast.2013.07.007_bib45","doi-asserted-by":"crossref","first-page":"R7","DOI":"10.1186\/bcr3378","article-title":"Mammographic density as a predictor of breast cancer survival: the Multiethnic Cohort","volume":"15","author":"Maskarinec","year":"2013","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.breast.2013.07.007_bib46","doi-asserted-by":"crossref","first-page":"6490","DOI":"10.1158\/0008-5472.CAN-09-0280","article-title":"Premenopausal mammographic density in relation to cyclic variations in endogenous sex hormone levels, prolactin, and insulin-like growth factors","volume":"69","author":"Walker","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.breast.2013.07.007_bib47","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1093\/aje\/kwi286","article-title":"The association of endogenous sex steroids and sex steroid binding proteins with mammographic density: results from the postmenopausal estrogen\/progestin interventions mammographic density study","volume":"162","author":"Greendale","year":"2005","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.breast.2013.07.007_bib48","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1158\/1055-9965.EPI-05-0828","article-title":"Associations among mammographic density, circulating sex hormones, and polymorphisms in sex hormone metabolism genes in postmenopausal women","volume":"15","author":"Warren","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.breast.2013.07.007_bib49","doi-asserted-by":"crossref","first-page":"R38","DOI":"10.1186\/bcr2325","article-title":"Sex steroids, growth factors and mammographic density: a cross-sectional study of UK postmenopausal Caucasian and Afro-Caribbean women","volume":"11","author":"McCormack","year":"2009","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.breast.2013.07.007_bib50","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0140-6736(04)17666-6","article-title":"Results of the ATAC (Arimidex, Tamoxifen, alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer","volume":"365","author":"ATAC Trialists' Group","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.breast.2013.07.007_bib51","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1056\/NEJMoa040331","article-title":"A\u00a0comparison of letrozole and tamoxifen therapy in postmenopausal women with primary breast cancer","volume":"350","author":"Breast International Group (BIG) 1-98 Collaborative Group","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.breast.2013.07.007_bib52","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1200\/JCO.2005.05.3694","article-title":"Adjuvant aromatase inhibitors for early breast cancer after chemothapy-induced amenorrhoea: caution and suggested guidelines","volume":"24","author":"Smith","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.breast.2013.07.007_bib53","doi-asserted-by":"crossref","first-page":"R21","DOI":"10.1530\/ERC-11-0199","article-title":"Recognizing menopause in women with amenorrhea induced by cytotoxic chemotherapy for endocrine-responsive early breast cancer","volume":"19","author":"Torino","year":"2012","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.breast.2013.07.007_bib54","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1093\/annonc\/mdj127","article-title":"Caution: vaginal estradiol appears to be contraindicated in postmenopausal women on adjuvant aromatase inhibitors","volume":"17","author":"Kendall","year":"2006","journal-title":"Ann Oncol"},{"key":"10.1016\/j.breast.2013.07.007_bib55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/bcr960","article-title":"Deficits in plasma oestradiol measurements in studies and management of breast cancer","volume":"7","author":"Dowsett","year":"2004","journal-title":"Brest Cancer Res"},{"key":"10.1016\/j.breast.2013.07.007_bib56","doi-asserted-by":"crossref","first-page":"3791","DOI":"10.1210\/jc.2005-2378","article-title":"Comparison of methods to measure low serum estradiol levels in postmenopausal women","volume":"91","author":"Lee","year":"2006","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.breast.2013.07.007_bib57","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1158\/1055-9965.EPI-06-0765","article-title":"Standardization of steroid hormone assays:\u00a0why, how and when?","volume":"16","author":"Stanczyk","year":"2007","journal-title":"Cancer Epidemiol Biomarkers Prev"}],"container-title":["The Breast"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977613001422?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977613001422?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:31:47Z","timestamp":1760776307000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960977613001422"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":57,"alternative-id":["S0960977613001422"],"URL":"https:\/\/doi.org\/10.1016\/j.breast.2013.07.007","relation":{},"ISSN":["0960-9776"],"issn-type":[{"value":"0960-9776","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sex hormones and breast cancer risk and prognosis","name":"articletitle","label":"Article Title"},{"value":"The Breast","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.breast.2013.07.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}